The research connecting semaglutide to allodynia The evidence linking semaglutide to allodynia comes from three distinct sources: clinical trial data, published case reports, and population-level epidemiological studies
By 2020, this had decreased to around 292,000
Factors that likely influence individual response include baseline heart rate, cardiovascular fitness level, autonomic nervous system tone, body composition, and potentially genetic variations in glucagon receptor density or sensitivity
Additionally, lifestyle factors play a significant role: weight gain, reduced physical activity, poor dietary adherence, or increased stress can all contribute to worsening glycaemic control, making it appear as though Rybelsus is no longer working